Universal Cells Employee Directory
Biotechnology ResearchWashington, United States11-50 Employees
Universal Cells is a private biotechnology company based in Seattle that develops stem cell lines designed for universal compatibility to support regenerative medicine. Its technology is anchored in intellectual property licensed from the University of Washington and encompasses genome-editing of human stem cells, including strategies to influence immune-related characteristics. The goal is to broaden the use of stem cell therapies by reducing barriers related to donor-recipient compatibility. In the biopharma research sector, the company has pursued collaborations with other biotech firms, including a 2025 partnership with Ginkgo Bioworks to optimize next-generation iPSC-derived cancer cell therapies. In 2026, the Seattle office was closed as part of consolidation of research activities by its owner, accompanied by a reduction in staff.